logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
E

Experimental Hematology & Oncology

IF13.5
论文数164
被引数
期刊论文 164
发表时间
delete
SCGB3A2 marks a low-angiogenesis tumor cell state associated with extracellular PGK2 and angiostatin in lung adenocarcinomaSCGB3A2标记与肺腺癌中低血管生成肿瘤细胞状态相关的细胞外PGK2和血管抑素
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-30
delete0
deleteOAAI
deleteShu-Lin Zhao; Yu Cao; Yi-Zuo Shi; Min Zhang; Fu-qiang Dai; Tian-Hu Wang; Wei Liang; Hong Zhang
delete分享
delete收藏
HER2 in solid tumors: microenvironment features and multifaceted advances from mechanisms to clinical translationHER2在实体瘤中：微环境特征及从机制到临床转化的多方面进展
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-28
delete0
deleteOAAI
deleteTianqi Zhang; Cong Tan; Hui Sun; Wenchao Gu; Wenfeng Wang; Midie Xu; Weiqi Sheng
delete分享
delete收藏
Glioblastoma as a dynamic tumor ecosystem: from molecular alterations to therapeutic translation胶质母细胞瘤作为一种动态肿瘤生态系统：从分子改变到治疗转化
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-28
delete0
deleteOAAI
deleteLukas Gorecki
delete分享
delete收藏
Timdarpacept (IMM01) combined with azacitidine (AZA) as first-line therapy in adults with higher risk chronic myelomonocytic leukemia (CMML): results from a prospective, multicenter, phase II studyTimdarpacept（IMM01）联合阿扎胞苷（AZA）作为高风险慢性粒单细胞白血病（CMML）成人患者的初始治疗：一项前瞻性、多中心、II期研究的结果
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-28
delete0
deleteOAAI
deleteLiya Ma; Wei Yang; Sujun Gao; Junmin Li; Qingsong Yin; Xingli Zhao; Xiaojing Yan; Sanfang Tu; Fei Li; Haiping Yang; Ronghua Hu; Shaoyuan Wang; Zheng Dong; Xiwen Zhao; Guodong Lu; Zhuli Wu; Wenzhi Tian; Hongyan Tong; Zhijian Xiao
delete分享
delete收藏
Correction: Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial更正：CD33靶向CAR-NK细胞疗法治疗复发/难治性AML的安全性与有效性：临床前评估和I期试验
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-26
delete0
deleteOAAI
deleteRuihao Huang; Xiaoqi Wang; Hongju Yan; Xu Tan; Yingying Ma; Maihong Wang; Xiao Han; Jia Liu; Li Gao; Lei Gao; Guangjun Jing; Cheng Zhang; Qin Wen; Xi Zhang
delete分享
delete收藏
Blocking aryl hydrocarbon receptor remodels myeloid–T cell crosstalk and enhances anti-PD-1 response in the tumor microenvironment阻断芳烃受体重塑髓系细胞-T细胞串扰并增强肿瘤微环境中的抗PD-1反应
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-26
delete0
deleteOAAI
deleteDong Kwon Kim; Sujeong Baek; Youngtaek Kim; Seung Min Yang; So Young Park; Su Jin Choi; Ju Hyeon Lee; Sang Hoon Lee; Jongho Cho; Daewon Cha; Dajeong Kim; Sunghwa Kim; Jae Hwan Kim; Byoung Chul Cho
delete分享
delete收藏
Correction: GPR109A controls neutrophil extracellular traps formation and improve early sepsis by regulating ROS/PAD4/Cit-H3 signal axis纠正：GPR109A通过调控ROS/PAD4/Cit-H3信号轴控制中性粒细胞胞外陷阱的形成并改善早期败血症
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-26
delete0
deleteOAAI
deleteWenjin Guo; Qian Gong; Xiaofeng Zong; Dianjun Wu; Yuhang Li; Huijie Xiao; Jie Song; Sheng Zhang; Shoupeng Fu; Zhichun Feng; Lu Zhuang
delete分享
delete收藏
Comparative characterization of OncoPro™ and Wnt-based media reveals distinct phenotypic and pharmacologic states in patient-derived tumor organoids比较OncoPro™和Wnt-based培养基的特性揭示患者来源肿瘤类器官中不同的表型和药理学状态
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-26
delete0
deleteOAAI
deleteSofie Seghers; Maxim Le Compte; Felicia Rodrigues Fortes; Jana Baroen; Jasper Ott; Geert Roeyen; Vera Hartman; Samir Kumar-Singh; Lenny Coppens; Michiel de Maat; Niels Komen; Sylvie Van Den Broeck; Jody Valk; Wiebren Tjalma; Jeroen M. H. Hendriks; Paul Van Schil; Gilles Van Haesendonck; Sofia L. J. Peeters; Hans Prenen; Christophe Deben
delete分享
delete收藏
Innovations and emerging trends in adoptive cell therapies for solid tumors: engineering strategies and clinical translation实体瘤的适应性细胞疗法创新与新兴趋势：工程策略与临床转化
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-22
delete0
deleteOAAI
deletePeng Huang; WenLin Wu; Yu Min; Yi Zhang; YunFeng Tao; Zheran Liu; Zhigong Wei; Xingchen Peng
delete分享
delete收藏
Oncogenic RAS as an adaptive signaling ecosystem: context-dependent vulnerabilities and resistance-informed therapeutic design致癌RAS作为一个适应性信号生态系统：依赖背景的脆弱性及耐药性指导的疗法设计
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-22
delete0
deleteOAAI
deleteAmir Abbas Hamidi; Omeed Moaven; Reihaneh Alsadat Mahmoudian; Mohammad Reza Abbaszadegan
delete分享
delete收藏
Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinomaCobimetinib通过改变my-CAFs来抑制BRAFV600E突变型未分化甲状腺癌的肿瘤生存和免疫逃逸
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-20
delete0
deleteOAAI
deleteMario Udinotti; Niclas Ramm; Thamer Abed Alhaleem Amin Hamdan; Muhammad Sameer Ali Khan; Udo Siebolts; Marcus Bauer; Kerstin Lorenz; Christine Dierks; Claudia Wickenhauser; Barbara Seliger
delete分享
delete收藏
Venetoclax-based combinations in high-risk myelodysplastic syndromes: highlights from ASH 2025 & EHA 2026维奈克拉为基础的联合疗法在高风险骨髓增生异常综合征中的应用：ASH 2025与EHA 2026会议亮点
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-16
delete0
deleteOAAI
deleteInes Zugasti; Marina Cornejo; Sandra Castaño-Diez; Juan Jose Rodriguez-Sevilla; Albert Cortes-Bullich; Jordi Esteve; Marina Diaz-Beya
delete分享
delete收藏
Intratumoral microbiota in cancer immunotherapy: metabolic-epigenetic crosstalk and engineered bacterial therapeutics肿瘤内微生物群在癌症免疫治疗中的作用：代谢-表观遗传交叉对话与工程细菌疗法
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-16
delete0
deleteOAAI
deleteNiying Zhao; Huan Zhang; Yutong Pang; Lingqin Zhu; Qinghua Liu; Zhiya Zhang; Lin Shen; Yuqi He; Shuye Lin
delete分享
delete收藏
Metabolic reprogramming in cancer-associated fibroblasts: orchestrating the tumor immune microenvironment and response to immune checkpoint blockade肿瘤相关成纤维细胞中的代谢重编程：调控肿瘤免疫微环境及对免疫检查点抑制剂的应答
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-10
delete0
deleteOAAI
deleteLuoman Gan; Zhonglong Liu; Liren Cao; Xiaoyan Meng; Xuanhao Liu; Xu Wang; Yue He
delete分享
delete收藏
Beyond MYD88-only testing: MYD88/CD79B profiling improves molecular detection and MCD genotyping in VRL and CNS lymphomas超越仅MYD88检测：MYD88/CD79B分析提高了VRL和CNS淋巴瘤的分子检测和MCD基因分型
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-09
delete0
deleteOAAI
deleteMona M. Wang; Yuanhan Li; Gee Fung How; Candice E.H. Ho; Nagavalli DO Somasundaram; Jason Yongsheng Chan; Timothy Kwang Yong Tay; Than Hein; Anita Sook Yee Chan
delete分享
delete收藏
Targeting adaptive EGFR feedback enhances the therapeutic efficacy of RMC-6236 in cholangiocarcinoma靶向适应性EGFR反馈增强RMC-6236在胆管癌中的治疗效果
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-03
delete0
deleteOAAI
deleteShiori Yamazaki; Nao Hondo; Koya Yasukawa; Masato Kitazawa; Satoshi Nakamura; Yuta Yamamoto; Satoru Miyazaki; Hirokazu Tanaka; Masatsugu Kuroiwa; Naoki Ishizaka; Tadaaki Shimizu; Akira Shimizu; Yuji Soejima
delete分享
delete收藏
Next-generation CAR-T therapy for malignant brain tumors: latest updates from the 2026 AACR Annual Meeting下一代CAR-T疗法治疗恶性脑肿瘤：2026年AACR年会最新进展
deleteExperimental Hematology & Oncology
IF13.5
delete2026-09-28
delete0
deleteOAAI
deleteValbert Oliveira Costa Filho; Silvia Helena Barem Rabenhorst; Felipe Pantoja Mesquita
delete分享
delete收藏
Daraxonrasib and the era of pan-RAS inhibition: mechanisms, clinical advances, and resistance landscapes达拉卡龙拉西布与泛RAS抑制时代：机制、临床进展及耐药景观
deleteExperimental Hematology & Oncology
IF13.5
delete2026-09-28
delete0
deleteOAAI
deleteJiacheng Lou; Danlu Zhang
delete分享
delete收藏
Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT成人AML完全缓解伴可测量微小残留病患者间基因半相合、同胞全相合及无关供者allo-HCT的比较：EBMT全球委员会和ALWP的研究
deleteExperimental Hematology & Oncology
IF13.5
delete2026-09-19
delete0
deleteOAAI
deleteYishan Ye; Jacques-Emmanuel Galimard; Myriam Labopin; Francis Ayuk; Ibrahim Yakoub-Agha; Matthias Stelljes; Urpu Salmenniemi; Thomas Schroeder; Gesine Bug; Maria-Pilar Gallego-Hernanz; Edouard Forcade; Jakob Passweg; Maija Itala-Remes; Simona Piemontese; Jaime Sanz; Ali Bazarbachi; Arnon Nagler; Eolia Brissot; Lin Li; Yi Luo; Jimin Shi; Yanmin Zhao; Mohamad Mohty; He Huang; Fabio Ciceri; Norbert Claude Gorin
delete分享
delete收藏
Dysregulated KMT2D mutant targeting immunogenic rewiring to overcome epigenetic entropy promotes follicular lymphomagenesisKMT2D突变导致的失调性靶向免疫重编程以克服表观遗传熵促进滤泡性淋巴瘤发生
deleteExperimental Hematology & Oncology
IF13.5
delete2026-09-15
delete0
deleteOAAI
deleteYuqian Zhu; Jingwei Yao; Yuelong Jiang; Qian Lai; Qinwei Chen; Jingxing Zhang; Manman Deng; Zhijuan Lin; Yiming Luo; Zhifeng Li; Long Liu; Zhong Zheng; Jie Zha; Bing Xu
delete分享
delete收藏